Rory B Riggs Calyxt, Inc. (CLXT) insider trading activity

Rory B Riggs is of Calyxt, Inc.. Currently has a direct ownership of 14.6 Million shares of CLXT, which is worth approximately $285 Million. The most recent transaction as insider was on Jun 09, 2025, when has been sold 4,050,000 shares (Class A Common Stock) at a price of $0.01 per share, resulting in proceeds of $40,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.6M

Infinity% 3M change

355.47% 12M change

Total Value Held $285 Million

RORY B RIGGS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 09 2025	BUY Exercise of in-the-money or at-the-money derivatives securities	$40,500 $0.01 p/Share	4,050,000 Added 21.74%	14,583,307 Class A Common Stock
Jun 05 2025	BUY Grant, award, or other acquisition	$10,000,000 $1.75 p/Share	5,714,286 Added 35.17%	10,533,307 Class A Common Stock
Dec 31 2024	SELL Conversion of derivative security	-	1,388,084 Reduced 100.0%	0 Class B Common Stock
Dec 31 2024	BUY Conversion of derivative security	-	1,388,084 Added 22.29%	4,839,912 Class A Common Stock
Sep 18 2024	BUY Grant, award, or other acquisition	$1,000,000 $4.0 p/Share	250,000 Added 6.75%	3,451,828 Class A Common Stock
Jun 11 2024	BUY Grant, award, or other acquisition	$1,000,007 $10.2 p/Share	98,040 Added 2.97%	3,201,828 Class A Common Stock
Dec 29 2023	SELL Conversion of derivative security	-	1,500,000 Reduced 52.32%	1,367,193 Class B Common Stock
Dec 29 2023	BUY Other acquisition or disposition	-	1,505,967 Added 34.44%	2,867,193 Class B Common Stock
Dec 29 2023	BUY Conversion of derivative security	-	1,500,000 Added 32.58%	3,103,788 Class A Common Stock
Dec 12 2023	BUY Open market or private purchase	$5,470,992 $10.58 p/Share	517,107 Added 24.17%	1,622,495 Class A Common Stock
Jun 01 2023	BUY Open market or private purchase	$31,500 $31.5 p/Share	1,000 Added 0.09%	1,154,464 Class A Common Stock
May 31 2023	BUY Grant, award, or other acquisition	-	1,022,055 Added 46.98%	1,153,464 Class A Common Stock
May 31 2023	BUY Grant, award, or other acquisition	-	1,361,226 Added 50.0%	1,361,226 Class B Common Stock

Also insider at

ITCI

Intra-Cellular Therapies, Inc. Healthcare

RPRX

Royalty Pharma plc Healthcare

Director

FGEN

FIBROGEN INC Healthcare

Director

RBR

Rory B Riggs

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLXT shares.

Notify only if

Value

Insider Trading

Get notified when an Calyxt, Inc. insider buys or sells CLXT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Calyxt, Inc.

Track Activities on CLXT

Account